Wellington Management Group Portfolio holdings
Wellington Management Group, founded in 1928 by Walter L. Morgan and headquartered in Boston, Massachusetts, is one of the world’s largest independent asset management firms, overseeing trillions in assets for a diverse client base including pension funds, endowments, and mutual fund investors. Renowned for its active management approach, Wellington offers a broad range of investment strategies across equities, fixed income, multi-asset, and alternative investments, emphasizing deep research and long-term partnerships with clients. The firm gained early fame for launching the Wellington Fund, one of the first balanced mutual funds, and has since maintained a reputation for disciplined, collaborative portfolio management. With a global presence and a focus on customized solutions, Wellington remains a trusted name in institutional and retail investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$1.53B |
| 2 |
Eli Lilly
LLY
|
+$874M |
| 3 |
Blackstone
BX
|
+$706M |
| 4 |
RTX Corp
RTX
|
+$576M |
| 5 |
American Express
AXP
|
+$574M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$3.43B |
| 2 |
American Tower
AMT
|
+$1.25B |
| 3 |
Amazon
AMZN
|
+$785M |
| 4 |
TSS
Total System Services, Inc.
TSS
|
+$714M |
| 5 |
Apple
AAPL
|
+$577M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 21.49% |
| 2 | Financials | 15.09% |
| 3 | Technology | 13.78% |
| 4 | Industrials | 11.01% |
| 5 | Consumer Discretionary | 9.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1626
Akebia Therapeutics
AKBA
$252M
| $1.57M | ﹤0.01% |
400,293
-10,065
| -2% | -$43.1K |
|
|
INFI
1627
DELISTED
Infinity Pharmaceuticals, Inc.
INFI
| $1.56M | ﹤0.01% |
1,518,465
-39,095
| -3% | -$53.3K |
|
1628
Banco Macro
BMA
$5.35B
| $1.56M | ﹤0.01% |
59,930
-67,451
| -53% | -$3.15M |
|
1629
Sasol
SSL
$7.1B
| $1.56M | ﹤0.01% |
91,512
+73,648
| +412% | +$1.5M |
|
|
ICPT
1630
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
| $1.55M | ﹤0.01% |
23,372
+5,788
| +33% | +$389K |
|
1631
Vipshop
VIPS
$7.53B
| $1.55M | ﹤0.01% |
173,755
-869,885
| -83% | -$7.11M |
|
1632
Viasat
VSAT
$11.1B
| $1.54M | ﹤0.01% |
20,510
+316
| +2% | +$25.2K |
|
1633
Brookfield
BN
$108B
| $1.54M | ﹤0.01% |
+81,526
| New | +$1.48M |
|
|
SWTX
1634
DELISTED
SpringWorks Therapeutics
SWTX
| $1.53M | ﹤0.01% |
+70,577
| New | +$1.67M |
|
1635
Telefônica Brasil
VIV
$19.2B
| $1.51M | ﹤0.01% |
114,954
-414,145
| -78% | -$5.5M |
|
1636
Grupo Aeroportuario Centro Norte
OMAB
$5.33B
| $1.49M | ﹤0.01% |
31,394
-222
| -0.7% | -$10.6K |
|
1637
Digital Realty Trust
DLR
$71.7B
| $1.48M | ﹤0.01% |
+11,430
| New | +$1.39M |
|
|
SC
1638
DELISTED
SANTANDER CONSUMER USA HOLDINGS INC
SC
| $1.48M | ﹤0.01% |
58,046
+13,299
| +30% | +$347K |
|
1639
Huntsman Corp
HUN
$1.77B
| $1.46M | ﹤0.01% |
62,950
-38,581
| -38% | -$797K |
|
1640
Westlake Corp
WLK
$9.9B
| $1.46M | ﹤0.01% |
22,253
+14,055
| +171% | +$905K |
|
|
AUD
1641
DELISTED
Audacy, Inc.
AUD
| $1.46M | ﹤0.01% |
436,592
-15,713
| -3% | -$70.5K |
|
1642
Kewaunee Scientific
KEQU
$106M
| $1.45M | ﹤0.01% |
93,238
-104,576
| -53% | -$1.76M |
|
|
GLBZ
1643
DELISTED
Glen Burnie Bancorp
GLBZ
| $1.45M | ﹤0.01% |
133,955
-15,732
| -11% | -$168K |
|
1644
Gerdau
GGB
$9.7B
| $1.44M | ﹤0.01% |
575,409
-1,814,965
| -76% | -$4.84M |
|
1645
Huntington Bancshares
HBAN
$35.5B
| $1.44M | ﹤0.01% |
100,763
-618,486
| -86% | -$8.46M |
|
|
INVX
1646
Innovex International
INVX
$1.97B
| $1.44M | ﹤0.01% |
28,633
+16,859
| +143% | +$823K |
|
1647
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
$17.9B
| $1.43M | ﹤0.01% |
16,450
-1,512,803
| -99% | -$131M |
|
1648
Kohl's
KSS
$2.19B
| $1.43M | ﹤0.01% |
28,785
-129,323
| -82% | -$6.34M |
|
|
FCCY
1649
DELISTED
1st Constitution Bancorp
FCCY
| $1.42M | ﹤0.01% |
75,681
-78,473
| -51% | -$1.4M |
|
1650
BBVA Argentina
BBAR
$3.49B
| $1.41M | ﹤0.01% |
+326,094
| New | +$2.54M |
|
Similar funds
Wellington Management Group's Q3 2019 Portfolio in Review
As of Q3 2019, Wellington Management Group held 2,207 positions worth $443B, down 1.8% from $452B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Wellington Management Group's Q3 2019 filing shows 166 new, 707 increased, 1,000 reduced and 194 closed positions. Its largest new stake was Cable One: 145,948 shares worth $183M. The largest sale was Allergan plc, an estimated $3.43B.
By sector, the portfolio is most concentrated in Healthcare at 21% of assets, down from 22% a quarter earlier, followed by Financials and Technology.
- Wellington Management Group's largest Q3 2019 buy was Cable One: 145,948 shares worth $183M.
- Wellington Management Group added most to Pfizer in Q3 2019, an estimated $1.53B increase.
- Wellington Management Group's biggest Q3 2019 reduction was Allergan plc, cutting an estimated $3.43B.
- Wellington Management Group fully exited Total System Services, Inc. in Q3 2019, selling an estimated $714M.
- Wellington Management Group's ten largest holdings make up 15% of its $443B portfolio in Q3 2019.
- Wellington Management Group opened 166 new positions and closed 194 in Q3 2019.
- Wellington Management Group's portfolio value fell 1.8% quarter-over-quarter to $443B.
Based on Wellington Management Group's 13F filing for Q3 2019, filed 13 Nov 2019.